Interventional cardiology is a subfield of cardiology that focuses on catheter-based therapy of heart conditions such as aneurysm, congenital heart defect, and coronary artery disease. The catheter is inserted into the femoral artery or any big peripheral vein or artery, and the entire process is performed utilizing fluoroscopy through the catheter.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/691
Statistics
The global interventional cardiology devices market is expected to be worth US$ 27,745.6 million in 2020, rising to US$ 45,754.1 million by the end of 2027.
Global Interventional Cardiology Devices Market: Drivers
The increasing incidences of cardiovascular disorders is expected to drive the global interventional cardiology devices market growth during the forecast period. According to the American Heart Association’s Heart and Stroke Statistics 2019 Release, in 2016 around 48 % of all people in the U.S. had some kind of cardiovascular disorder.
Furthermore, rising demand for minimally invasive operations is expected to boost the global interventional cardiology devices market growth over the forecast period. Due to the sheer following points, minimally invasive surgeries are preferred by patients:
- There are fewer post-surgery problems and negative effects.
- Patient recovering time is reduced, and pain is minimized.
Statistics:
Stents accounted for the largest share in the global interventional cardiology devices market in 2019, representing 84.5 % of the market share, trailed by PTCA Guidewires and Angiography Catheters.
Request Here For FREE PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/691
Global Interventional Cardiology Devices Market: Restraints
Challenges related to interventional cardiology treatments are expected to hamper the global interventional cardiology devices market growth over the forecast period. The following problems are connected with interventional cardiology surgeries:
- Stent thrombosis occurs when blood clots develop around the stents.
- Restenosis is the reappearance of stenosis (an unnatural narrowing of an artery) after corrective surgery.
- Since some of the stents are metallic, an MRI scan cannot be performed.
Furthermore, high approval standards and government regulations are expected to hinder the global interventional cardiology devices market growth over the forecast period. The U.S. Food and Drug Administration and CE classify interventional cardiology devices as high-risk class III medical devices. This complicates the device approval process and makes it lengthy, severe, and costly.
Global Interventional Cardiology Devices Market: Opportunities
The growing geriatric population would provide attractive growth prospects for players in the global interventional cardiology devices market. According to the U.S. Census Bureau, the elderly population in the U.S. is expected to be worth 77 million by 2034.
Furthermore, the implementation of remote PCI procedures is expected to boost the global interventional cardiology devices market growth over the forecast period. For instance, in December 2018, 5 patients at the Apex Heart Institute in Ahmedabad, India, completed an elective PCI surgery using CorPath technology at a distance of around 20 miles or 32km.
The global interventional cardiology devices market was worth $25,847.2 million in 2019 and is expected to reach $45,754.1 million by 2027, growing at a 7.4 % CAGR during the forecast period 2020 and 2027.
Market Trends/Key Takeaways
The rising number of PCI procedures is expected to boost the global interventional cardiology devices market growth over the forecast period. For instance, according to a report issued in April 2019 by the National Intervention Council, India, and Apollo Health City, India, around 3,87,416 PCI operations were conducted in 705 facilities in India in 2017, representing a 3.7 % increase from 2016.
Key players in the global interventional cardiology devices market are focusing on new product approvals and release to grow their product offering. For instance, Terumo Corporation, a Tokyo-based medical device firm, obtained a CE mark for Ultimaster TANSEI, a drug-eluting stent in April 2018.
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/691
Global Interventional Cardiology Devices Market: Competitive Landscape
Key players contributing to the global interventional cardiology devices market are SINOMED, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG., Terumo Medical Corporation, Biotronik SE & Co. KG, Cardinal Health, Abbott Laboratories, and Cook Medical.
Global Interventional Cardiology Devices Market: Key Developments
The global interventional cardiology devices market’s major players are focusing on R and d to extend their product range. For instance, SINOMED completed enrolment in the PIONEER III randomized, supervised clinical study in July 2019 to investigate the efficacy and safety of the BuMA Supreme DES in order to get major regulatory approvals for the BuMA Supreme Drug-Eluting Stent System.
Reasons to Purchase this Report
• Current and future of global Interventional Cardiology Devices Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/691
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Device
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Interventional Cardiology Devices Market, By Device, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Angiography Catheters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- IVUS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- PTCA Guidewires
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Guiding Catheters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Balloon Inflation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Interventional Cardiology Devices Market, By End User, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Interventional Cardiology Devices Market, By Regions, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837